← 返回

免疫细胞的受体介导对肿瘤的识别

英文原题:Receptors of immune cells mediates recognition for tumors.

查看英文原题

Receptors of immune cells mediates recognition for tumors.

PubMed 2022/11/02(内容时间) Prog Mol Biol Transl Sci

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

在过去的几十年里,借助癌症免疫治疗,免疫系统被引导朝向根除癌细胞的方向发展。T细胞、B细胞、单核细胞/巨噬细胞、树突状细胞、T-reg细胞和自然杀伤(NK)细胞是在癌细胞检测、炎症减轻以及抗肿瘤反应中发挥重要作用的众多免疫细胞类型中的一部分。简而言之,嵌合抗原受体、过继转移和免疫检查点调节剂目前是成功开展基于免疫治疗的多种癌症治疗的研究重点。本章讨论了关于免疫细胞受体,尤其是淋巴细胞和单核细胞/巨噬细胞的受体如何调控免疫系统对恶性肿瘤的检测机制及其最新进展的正在进行的研究。我们还将探讨基于这些机制的治疗策略。

展开英文摘要原文

Over the last few decades, the immune system has been steered toward eradication of cancer cells with the help of cancer immunotherapy. T cells, B cells, monocytes/macrophages, dendritic cells, T-reg cells, and natural killer (NK) cells are some of the numerous immune cell types that play a significant part in cancer cell detection and reduction of inflammation, and the antitumor response.

Briefly stated, chimeric antigen receptors, adoptive transfer and immune checkpoint modulators are currently the subjects of research focus for successful immunotherapy-based treatments for a variety of cancers. This chapter discusses ongoing investigations on the mechanisms and recent developments by which receptors of immune cells especially that of lymphocytes and monocytes/macrophages regulate the detection of immune system leading to malignancies.

We will also be looking into the treatment strategies based on these mechanisms.

论文信息

作者
Anang V、Singh A、Kottarath SK、Verma C
第一作者单位
International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.India
通讯作者单位
Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH, United States. Electronic address: chaitenya999@gmail.com.United States
期刊
Progress in molecular biology and translational science2023
原文标识
PubMed 36631194 · DOI 10.1016/bs.pmbts.2022.09.009